Pajek, Maja and Sember, Vedrana and Čuk, Ivan and Šimenko, Jožef and Pajek, Jernej (2021) Comparison of Body Composition Monitor and InBody 720 Bioimpedance Devices for Body Composition Estimation in Hemodialysis Patients and Healthy Controls. Symmetry, 13 (1). p. 150. DOI https://doi.org/10.3390/sym13010150
Pajek, Maja and Sember, Vedrana and Čuk, Ivan and Šimenko, Jožef and Pajek, Jernej (2021) Comparison of Body Composition Monitor and InBody 720 Bioimpedance Devices for Body Composition Estimation in Hemodialysis Patients and Healthy Controls. Symmetry, 13 (1). p. 150. DOI https://doi.org/10.3390/sym13010150
Pajek, Maja and Sember, Vedrana and Čuk, Ivan and Šimenko, Jožef and Pajek, Jernej (2021) Comparison of Body Composition Monitor and InBody 720 Bioimpedance Devices for Body Composition Estimation in Hemodialysis Patients and Healthy Controls. Symmetry, 13 (1). p. 150. DOI https://doi.org/10.3390/sym13010150
Abstract
Bioelectric impedance devices have become a standard of care not only for peritoneal dialysis but also for hemodialysis patients. We compared the most important body composition variables (extracellular water, intracellular water, total body water and fat mass) measured with the multifrequency bioelectric impedance device InBody 720 (MF-BIA) and bioimpedance spectroscopy body composition monitor Fresenius (BIS BCM) in hemodialysis patients (n = 51, 175.1 + 7.8 cm, 82.2 + 15.2 kg) and healthy controls (n = 51, 175.1 + 7.6 cm, 82.3 + 15.3 kg). The MF-BIA InBody 720 device compared to the BIS BCM device showed significantly larger total body water and intracellular water estimates and significantly smaller extracellular water and body fat estimates in hemodialysis patients (p < 0.001). These differences (p < 0.001) were similar in the cohort of healthy controls; moreover, we observed high correlations in all variables between the hemodialysis patients and the healthy controls (0.80–0.95, p < 0.001). The mean relative differences in the order of 8% were lower for extracellular water and total body fat, but the limits of agreement were still wide enough to be clinically significant. We conclude that the results of the measurements with InBody 720 and BCM Fresenius cannot be used interchangeably. Physicians and nutritionists involved in the care of hemodialysis patients should be aware of this discrepancy between the two devices and should try to use the same device to track the body in their hemodialysis population in a longitudinal direction.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | bioimpedance; Fresenius; InBody 720; body composition monitor; hemodialysis patients; chronic kidney disease |
Divisions: | Faculty of Arts and Humanities |
SWORD Depositor: | Unnamed user with email elements@essex.ac.uk |
Depositing User: | Unnamed user with email elements@essex.ac.uk |
Date Deposited: | 25 Jan 2021 12:54 |
Last Modified: | 30 Oct 2024 17:09 |
URI: | http://repository.essex.ac.uk/id/eprint/29615 |
Available files
Filename: symmetry-13-00150.pdf
Licence: Creative Commons: Attribution 3.0